Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
- Koen Vercauteren
- , Richard J.P. Brown
- , Ahmed Atef Mesalam
- , Juliane Doerrbecker
- , Sabin Bhuju
- , Robert Geffers
- , Naomi Van Den Eede
- , C. Patrick McClure
- , Fulvia Troise
- , Lieven Verhoye
- , Thomas Baumert
- , Ali Farhoudi
- , Riccardo Cortese
- , Jonathan Ball
- , Geert Leroux-Roels
- , Thomas Pietschmann
- , Alfredo Nicosia
- , Philip Meuleman
- Ghent University
- TWINCORE
- Helmholtz Centre for Infection Research
- University of Nottingham
- Ceinge Biotecnologie Avanzate
- Institut national de la santé et de la recherche médicale
- Université de Strasbourg
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig
- University of Naples Federico II
Research output: Contribution to journal › Article › peer-review
24
Citations
(Scopus)